Home › Vulvar Cancer › Maryland
Vulvar Cancer clinical trials in Maryland
3 studies for Vulvar Cancer are looking for participants at sites in Maryland.
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- National Institutes of Health, Bethesda
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 11, 2026 · NCT05592626E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jun 12, 2026 · NCT05686226Image-Guided Gynecologic Brachytherapy
- The SKCCC at Johns Hopkins, Baltimore
Recruiting
Ages 18 to 100 · Women · Updated Dec 18, 2025 · NCT02993900From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.